Kyocera (OTCMKTS:KYOCY) Trading Down 2.3% – What’s Next?

Shares of Kyocera Corporation (OTCMKTS:KYOCY) were down 2.3% on Tuesday . The stock traded as low as $10.72 and last traded at $10.74. Approximately 53,251 shares were traded during trading, a decline of 23% from the average daily volume of 69,243 shares. The stock had previously closed at $10.99.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Kyocera from a “sell” rating to a “hold” rating in a research report on Thursday, May 22nd.

Kyocera Stock Down 2.3%

The company has a current ratio of 2.92, a quick ratio of 1.86 and a debt-to-equity ratio of 0.06. The stock has a market cap of $15.13 billion, a P/E ratio of 89.50 and a beta of 0.32. The firm has a 50-day simple moving average of $11.86 and a two-hundred day simple moving average of $11.40.

Kyocera (OTCMKTS:KYOCY) last posted its quarterly earnings data on Wednesday, May 14th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). The firm had revenue of $3.57 billion for the quarter, compared to the consensus estimate of $515.77 billion. Kyocera had a return on equity of 0.71% and a net margin of 1.15%. Equities research analysts expect that Kyocera Corporation will post 0.32 earnings per share for the current fiscal year.

Kyocera Company Profile

Kyocera Corporation develops, produces, and distributes products based on fine ceramic technologies in Japan, rest of Asia, Europe, the United States, and internationally. It operates through Core Components Business, Electronic Components Business, and Solutions Business segments. The Core Components Business segment offers components, such as fine ceramic components for semiconductor processing equipment, automotive camera modules, and ceramic packages, as well as organic packages and boards to protect electronic components and ICs to industrial machinery, automotive-related, and the information and communication-related markets; optical components, and jewelry and applied ceramic related products; and medical devices comprising prosthetic joints and dental implants.